Ioanna Kokkinopoulou

Rimini 1 Str, Haidari
Athens, ESYE31 12462, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Retraction Note: Glutamine synthetase regulation by dexamethasone, RU486, and compound A in astrocytes derived from aged mouse cerebral hemispheres is mediated via glucocorticoid receptor.

Retraction Note: Glutamine synthetase regulation by dexamethasone, RU486, and compound A in astrocytes derived from aged mouse cerebral hemispheres is mediated via glucocorticoid receptor.

Journal: Molecular and cellular biochemistry

Published: April 19, 2025

Thioredoxin-Interacting Protein (TXNIP) in Gestational Diabetes Mellitus.

Thioredoxin-Interacting Protein (TXNIP) in Gestational Diabetes Mellitus.

Journal: Metabolites

Published: March 30, 2025

Angiotensin-converting-enzyme insertion/deletion polymorphism, ACE activity, and COVID-19: A rather controversial hypothesis. A case-control study.

Angiotensin-converting-enzyme insertion/deletion polymorphism, ACE activity, and COVID-19: A rather controversial hypothesis. A case-control study.

Journal: Journal of medical virology

Published: August 25, 2021

Glucocorticoid Receptor Signaling in Diabetes.

Glucocorticoid Receptor Signaling in Diabetes.

Journal: International journal of molecular sciences

Published: July 15, 2021

Mitochondrial Glucocorticoid Receptors and Their Actions.

Mitochondrial Glucocorticoid Receptors and Their Actions.

Journal: International journal of molecular sciences

Published: May 15, 2021

Glutamine synthetase regulation by dexamethasone, RU486, and compound A in astrocytes derived from aged mouse cerebral hemispheres is mediated via glucocorticoid receptor.

Glutamine synthetase regulation by dexamethasone, RU486, and compound A in astrocytes derived from aged mouse cerebral hemispheres is mediated via glucocorticoid receptor.

Journal: Molecular and cellular biochemistry

Published: December 19, 2020

Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome.

Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome.

Journal: Diabetes research and clinical practice

Published: July 04, 2019

Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals.

Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals.

Journal: Endocrine

Published: June 14, 2019

Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk.

Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk.

Journal: Scientific reports

Published: June 27, 2018

Effect of Vinca Alkaloids on the Expression Levels of microRNAs Targeting Apoptosis-related Genes in Breast Cancer Cell Lines.

Effect of Vinca Alkaloids on the Expression Levels of microRNAs Targeting Apoptosis-related Genes in Breast Cancer Cell Lines.

Journal: Current pharmaceutical biotechnology

Published: June 23, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026